Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

New CRISPR Device Diagnoses COVID in an Hour, Detects Variants

A team of engineers from MIT and Harvard University has developed a COVID diagnostic device with a tiny footprint but huge potential. The tabletop instrument costs around $15 to manufacture and is powered by CRISPR technology. It provides COVID results from spit samples in an hour. In their new study published in Science Advances, the researchers report that the device is incredibly accurate, matching performance levels of the current gold standard, the PCR test. Moreover, the technology can be adapted to identify SARS-CoV-2 variants, making it easy to track the circulation of these mutants without the need for genetic sequencing facilities.